News

FDA approves new generic valsartan; Alkem Laboratories bags the grant

U.S. Food and Drug Administration has approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure.

Read More

Mar 13, 2019

By : Team ABLE

Piramal to launch Cinacalcet with partner Slate Run Pharmaceuticals’ aid in the US

Cinacalcet tablets are indicated for the treatment of secondary hyperthyroidism in adult chronic kidney disease patients on dialysis and hypercalcemia in adult patients with parathyroid carcinoma.

Read More

Mar 13, 2019

By : Team ABLE

Fujifilm to acquire large-scale biologics manufacturing site from Biogen

Upon closure of this transaction, Biogen Hillerød will become Fujifilm's fourth biopharmaceutical contract development and manufacturing site.

Read More

Mar 13, 2019

By : Team ABLE

Regeneron and GSK make available new genetic data on 50,000 UK Biobank Participants to research community

Regeneron with the support of GSK and UK Biobank have announced that a vast tranche of new human sequencing data is now available to health researchers, offering an unprecedented ‘Big Data’ resource to enhance understanding of human biology and aid in therapeutic discovery.

Read More

Mar 13, 2019

By : Team ABLE

C-CAMP gets selected by CARB-X for its prestigious Global Accelerator Network

CARB-X is the world’s largest public-private partnership devoted to early development antibacterial R&D.

Read More

Mar 12, 2019

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights